Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Acutus Medical Inc AFIB

Healthcare Medical Devices
Acutus Medical, Inc. is focused on the production of left-heart access products under its distribution agreement with Medtronic, Inc. (Medtronic). The Company is solely focused on supporting the manufacturing and distribution of products to Medtronic. It manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or... see more

Recent & Breaking News (OTCPK:AFIB)

Acutus Medical Reports First Quarter 2024 Financial Results

GlobeNewswire May 9, 2024

Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire April 1, 2024

Acutus Medical to Cancel Third Quarter 2023 Conference Call

GlobeNewswire November 10, 2023

Acutus Medical Reports Third Quarter 2023 Financial Results

GlobeNewswire November 8, 2023

Acutus Medical Announces Strategic Realignment of Resources and Corporate Restructuring

GlobeNewswire November 8, 2023

Acutus Medical to Announce Third Quarter 2023 Financial Results

GlobeNewswire November 2, 2023

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire November 2, 2023

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 2, 2023

Acutus Medical Reports Second Quarter 2023 Financial Results

GlobeNewswire August 7, 2023

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire August 1, 2023

Acutus Medical to Present at the 43rd Annual Canaccord Growth Conference

GlobeNewswire July 27, 2023

Acutus Medical to Announce Second Quarter 2023 Financial Results

GlobeNewswire July 24, 2023

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire July 3, 2023

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire June 1, 2023

Acutus Medical to Showcase Innovative Cardiac Mapping and Ablation Technologies at HRS 2023

GlobeNewswire May 15, 2023

Acutus Medical Reports First Quarter 2023 Financial Results

GlobeNewswire May 11, 2023

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire May 2, 2023

Acutus Medical to Announce First Quarter 2023 Financial Results

GlobeNewswire April 28, 2023

Acutus Medical Announces Preliminary Unaudited First Quarter 2023 Results

GlobeNewswire April 20, 2023

RECOVER AF Study Reports 91% of First Redo Patients Achieved Freedom from AF at One Year After AcQMap-guided Ablation Therapy

GlobeNewswire April 20, 2023